Long-term outcomes of metabolic surgery versus medical/lifestyle therapy on metabolic dysfunction-associated fatty liver disease in adults with obesity and type 2 diabetes.
Saved in:
| Title: | Long-term outcomes of metabolic surgery versus medical/lifestyle therapy on metabolic dysfunction-associated fatty liver disease in adults with obesity and type 2 diabetes. |
|---|---|
| Authors: | Lundholm MD; Department of Endocrinology, Diabetes and Metabolism Cleveland Clinic, Cleveland, Ohio, USA., Kirschling S; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA., Hu B; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA., Aminian A; Bariatric and Metabolic Institute, Department of General Surgery, Cleveland Clinic, Cleveland, Ohio, USA., Arterburn DE; Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA., Courcoulas AP; Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Cummings DE; Department of Metabolism, Endocrinology, and Nutrition, University of Washington and VA Puget Sound Health Care System, Seattle, Washington, USA., Gourash WF; Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Patti ME; Research Division, Joslin Diabetes Center, and Harvard Medical School, Boston, Massachusetts, USA., Schauer PR; Metamor Institute, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA., Simonson DC; Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA., Vernon AH; Division of General & GI Surgery, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA., Kirwan JP; Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA., Kashyap SR; Weill Cornell Medicine Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, New York, New York, USA. |
| Source: | Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Dec; Vol. 26 (12), pp. 6055-6061. Date of Electronic Publication: 2024 Sep 12. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1463-1326 |
|---|---|
| DOI: | 10.1111/dom.15932 |